ACTN1 and hepatocellular carcinoma: Focusing on Scn8a, Actn1, Srd5a, NFkB2 and Neurl1b, we used shRNA-mediated targeting to lower their expression levels in Alb-R26Met HCC cells (Fig. 7a, Supplementary Fig. 13).